DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 246 participants.
Also called NCT02666742
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 246 participants
- Registry
-
NCT02666742
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, India
- Registry status
- Completed
Technical summary
Registry record NCT02666742. Randomized; no masking; primary purpose prevention. Start 2017-02-16 (actual); primary completion 2020-05-01 (actual). Results posted on 2021-09-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation
- Acronym
- STROKE-VT
- Condition
- Ventricular Tachycardia
- Condition
- Premature Ventricular Contraction
- Condition
- Stroke
- Intervention (Drug)
- DOAC
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Kansas City Heart Rhythm Institute
- Collaborator
- Kansas City Heart Rhythm Research Foundation
Record details
- Record id
cardio:ct-nct02666742- Content hash
a8681c03a077c0bd1e9dacf70f5078760333b334c15ec2105288fb23f4f9f3f6